undamentalytics Newsletter
Sign in

Heartsciences Inc. key statistics and ratios

In fiscal 2026, Heartsciences Inc. had an operating margin of -194787.4%, debt equal to 1602.3% of equity and a current ratio of 0.53. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Apr 20222023Apr 20232024Apr 20242025Apr 20252026Apr 2026LTMJul 2026
Gross margin45.1%45.7%67.3%56.8%59.1%60.9%
Operating margin<−999%<−999%<−999%<−999%<−999%<−999%
Net margin<−999%<−999%<−999%<−999%<−999%<−999%
Free-cash-flow margin<−999%<−999%<−999%<−999%<−999%<−999%
Return on equity——−175.0%———
Return on assets−231.1%−236.4%−103.3%−127.7%−192.8%−228.0%
Asset turnover0.010.000.000.000.000.00
Current ratio0.561.474.200.590.530.14
Debt to equity—433.7%6.8%>999%>999%—
Interest cover (operating income ÷ interest)n/mn/mn/mn/mn/mn/m
R&D as % of revenue>999%>999%>999%>999%>999%>999%
SG&A as % of revenue>999%>999%>999%>999%>999%>999%
Capital spending as % of revenue13.4%355.5%346.5%72.6%82.3%0.0%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: CUPR vs HSCSHSCS vs POASHSCS vs PAVM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Heartsciences Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Heartsciences Inc.